Similarly to people, other immunotherapy treatments like Bacillus Calmette–Guérin (BCG) and nano-immunotherapy have proven to affect PD-1/PD-L1 expression in canine urothelial carcinoma [65]. Here, CD274 is linked to urothelial carcinoma.